LINC01056 and hepatocellular carcinoma: To explore whether the Linc01056 knockdown-induced metabolic reprogramming from glycolysis towards FAO is due to direct inhibition of glycolysis by Linc01056, we cotreated HCC cells with the glycolytic inhibitor 2-DG in the presence of sorafenib.